Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Урогенитальные заболевания, вызванные Mycoplasma genitalium

Список литературы

  1. Ishihara S, Yasuda M, Ito S, Maeda S, Deguchi T. Mycoplasma genitalium urethritis in men. Intern. J. Antimicrob. Agent. 2004;24:23-7.
  2. Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, Sinei SK, Bwayo JJ, Totten PA. Association between Mycoplasma genitalium and acute endometritis. Lancet. 2002;359:765-66.
  3. Sonnenberg P, Ison CA, Clifton S et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol. 2015;44:1982-1994.
  4. Manhart LE, Critchlow CW, Holmes KK et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis. 2003;187:650-657.
  5. Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect. 2005;81:458-462.
  6. Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect. 2005;81:73-78.
  7. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. Clin Infect Dis 2010;51:1160-1166.
  8. Cohen CR, Mugo NR, Astete SG et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect. 2005;81:463-466.
  9. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015; 6:418-426.
  10. Wroblewski JKH et al. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium. Journal of clinical microbiology. 2006; 44(9):3306-3312.
  11. Carlsen KH, Jensen JS. Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? Journal of Clinical Microbiology. 2010;48(10): 3624-3627.
  12. European guideline on the management of Mycoplasma genitalium infections. 2021. DOI: 10.1111/jdv.17972.
  13. Кубанова А.А., Рахматулина М.Р. Урогенитальные инфекционные заболевания, вызванные генитальными микоплазмами. Клинические рекомендации. Вестник дерматологии и венерологии.  2009;(3):78-84.
  14. Рахматулина М. Р. Урогенитальные заболевания, вызванные генитальными микоплазмами (Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis).  Consilium medicum. 2012;(2):22-25.
  15. Рахматулина М.Р., Касаткина И.С. Современные представления о роли генитальных микоплазм в развитии патологических процессов урогенитальной системы, методах их диагностики и лечения у детей. Вестник дерматологии и венерологии. 2011;(1):15-23.
  16. Liu Z, Wang J, Zhu C. Clinical Practice Guidelines for the Diagnosis and Treatment of Ureaplasma Urealyticum Infections are Needed. Austin Clin Microbiol. 2016;1(1):1001.
  17.  Daley GM,  Russell DB,  Tabrizi SN. Mycoplasma genitalium: a review. Int J STD AIDS.  2014;25(7):475-87. doi: 10.1177/0956462413515196.
  18. Wei-Na Li , Wen-Bing Zhu , Gang Liu. Correlation of Mycoplasma genitalium infection with male infertility. Article in Chinese. Zhonghua Nan Ke Xue. 2018;24(11):999-1004.
  19.  Conway R,  Cook S,  Soni S. Antibiotic treatment of Mycoplasma genitalium infection. The Pharmaceutical Journal.  2019;303(7928): online DOI: 10.1211/PJ.2019.20206592
  20. Мавров Г.И., Федорович Т.В. Урогенитальный микоплазмоз: непростой выбор антибактериальной терапии (обзор литературы и собственные исследование). Украинский журнал дерматологии, венерологии и косметологии. 2016;1(60).
  21. Lars Falk, Martin Enger, Jørgen Skov Jensen. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. Journal of Antimicrobial Chemotherapy. 2015;70(11):3134- 3140 https://doi.org/10.1093/jac/dkv246
  22. Coorevits L, Traen A, Bingé L. et al. Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus. Clin Microbiol Infect. 2018;17.pii:S1198-743X(18)30223-4. DOI: 10.1016/j.cmi.2018.03.013. 
  23. Sloan B, Scheinfeld N. The use and safety of doxycycline hyclate and other Second generation tetracyclines. Expert opinion on drug safety. 2008;7(5):5717.
  24. Mroczkowsky TF, Mena L, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium (MG) positive urethritis. 16th Biennial Meeting of the International Society of Sexually Transmitted Disease (ISSTDR), Amsterdam, The Netherlands 2005;304-305.
  25. Mena LA, Mroczkowski TF, Nsuami M, et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis. 2009;48:1649-54.
  26. Durukan D, Read TRH, Murray G, et al. Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline 2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. Clin Infect Dis. 2020;71:1461-8.
  27. Li Y, Le WJ, Li S, Cao YP, Su XH. Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS. 2017;28:1106-14.
  28. Mondeja BA, Couri J, Rodríguez NM, Blanco O, Fernández C, Jensen JS. Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem. BMC Infect Dis 2018;18:601.
  29. Glaser AM, Geisler WM, Ratliff AE, Xiao L, Waites KB, Gaisa M. Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline. Int J STD AIDS. 2019; 30:512-4.
  30. Doyle M, Vodstrcil LA, Plummer EL, Aguirre I, Fairley CK, Bradshaw CS. Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance. Open Forum Infect Dis. 2020;7:ofaa291.
  31. Guschin A, Ryzhikh P, Rumyantseva T, Gomberg M, Unemo M. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect Dis. 2015;3(15):40.
  32. Andreeva IV, Kozlov SN, Korolev SV, Belikov AN, Grinev AV, Evstaf"ev VV, Kirpicheva NN, Serdiutskaia MV, Stetsiuk OU, Fokin AA, Khrianin AA. Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study. Antibiot Khimioter. 2012;57(5-6):32-40.
  33. Guo X., Ye Z., Deng R. Male urogenital tract mycoplasma infection and drug-resistance evolution. Josamycin - das bessere Makrolid? Zhonghua Nan Ke Xue. 2004;10(2):122-124.
  34. Anagrius C, Lore B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013;8:e61481.
  35. CDC Sexually Transmitted Infections Treatment Guidelines, 2021.
  36. Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015;60:1228–36.
  37. Asenjo A, Kusters JG, Severs TT, Alós JI. Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. Enfermedades Infecciosas y Microbiología Clínica. 2018;36(3):169-171. 
  38. Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, Aasterod M, Ringlander J, Nilsson CS, Sundqvist M, Schonning K, Moi H, Westh H, Jensen JS. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway, and Sweden in 2016. Clin Microbiol Infect. 2018;24(5):533-539.
  39. Pitt R, Fifer H, Woodford N, Alexander S. Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services in England. Sex Transm Infect. 2018;94(1):9-13.
  40. Tagg KA, Jeoffreys NJ, Couldwell DL, Donald JA, Gilbert GL. Fluoroquinolone, and macrolide resistance-associated mutations in Mycoplasma genitalium. J Clin Microbiol. 2013;51(7):2245-2249.
  41. Pond MJ, Nori AV, Witney AA, Lopeman RC, Butcher PD, Sadiq ST. High prevalence of antibiotic-resistant Mycoplasma genitalium in non-gonococcal urethritis: the need for routine testing and the in adequacy of current treatment options. Clin Infect Dis. 2014;58(5):631-637.
  42. Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30: 1650-1656. https://doi.org/10.1111/jdv.13849.
  43. Soni S, Horner P, Rayment M et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019;30:938-950.
  44.  Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvise P. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG An International Journal of Obstetrics and Gynaecology. 2010;(18):1475-1484.
  45. Ross JDC, Cronje ́ HS, Paszkowski T, Rakoczi I, Vildaite D, Kureishi A, Alefelder M, Arvis P, Reimnitz P, on behalf of the MAIDEN Study Group. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex Transm Infect. 2006;82:446-451.
  46. Surico N, Tavassoli K. Treatment of pelvic inflammatory disease with combined piperacillin and minocycline therapy. Panminerva Med. 1990 Oct-Dec;32(4):184-9. PMID: 2090993.
  47. Czeizel AE, Rockenbauer M, Olsen J, Sørensen HT. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand. 2000 Mar;79(3):234-7.
  48. Юрьев С.Ю., Аббасова В.И., Девятьярова Л.Л., Гущин А.Е. К вопросу о специфичности влияния Mycoplasma genitalium на течение беременности. Гинекология. 2009(4):20-3.
  49. Васильев М.М., Наволоцкая Т.И., Смирнова А.А., Фриго Н.В.,  Ротанов С.В., Сидорович С.Ю. Применение джозамицина (вильпрафена) у женщин с хламидийной инфекцией нижних и верхних отделов мочеполового тракта. Вестник дерматологии и венерологии. 2005; (3):78-80.
  50. Кузьмин В.Н., Гусейнзаде М.И. Эффективная антибактериальная терапия микоплазменной инфекции у женщин репродуктивного возраста. Лечащий врач. 2014;(3).
  51. Малова И.О., Храмова Т.Г. Эффективность джозамицина у девочек с урогенитальной инфекцией, вызванной Мycoplasma genitalium. Эффективная фармакотерапия. Акушерство и Гинекология. 2007;(4).
  52. Ye G, Jiang Z, Wang M, Huang J, Jin G, Lu S. The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem Biophys. 2014 Jan;68(1):207-10. DOI 10.1007/s12013-013-9691-8.
  53.  Zhu C, Liu J, Ling Y, Dong C, Wu T, Yu X, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Indian J Dermatol Venereol Leprol. 2012;78:406-407. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microb
  54. Infect. 2010;16:1649-1655.
  55. Zhonghua Liu, Jun Wang, Changtai Zhu Clinical Practice Guidelines for the Diagnosis and Treatment of Ureaplasma Urealyticum Infections are NeededAustin Clin Microbiol. 2016;1(1):1001.
  56. Рахматулина М.Р. Тактика диагностики и терапии урогенитальной микоплазменной инфекции согласно Федеральным клиническим рекомендациям. Фарматека. 2016;(3):33-38.
  57. Qing-Yong Wang, Rong-Hai Li, Lu-Qing Zheng, Xiao-Hong Shang. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013. Journal of Microbiology, Immunology and Infection. 2016;(49):359-362.
  58. Foschi C, Salvo M, Galli S, Moroni A, Cevenini R, Marangoni A. Prevalence and antimicrobial resistance of genital Mollicutes in Italy over a two-year period. New Microbiologica. 2018;41(2):153-158.
  59. Changtai Zhu, Jinming Liu, Yang Ling , Chunlei Dong, Tingting Wu, Xiaoyuan Yu, Yanfeng Hou, Liping Dong, Xiaowei Cheng. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Net Study. 2012;78(3):406-407.
  60. Díaz L, Cabrera LE, Fernández T, Ibáñez I, Torres Y, Obregón Y, Rivero Y. Frequency and antimicrobial sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in patients with vaginal discharge. MEDICC Review. 2013;15(4):45-47.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*